Angeion patents named in Pacesetter suit:
This article was originally published in Clinica
St Jude's Pacesetter subsidiary has amended its patent infringement suit against Guidant's CPI unit to include several patents held by Angeion. The suit was filed by Pacesetter in the federal district court of Delaware on May 3rd (see Clinica No 705, p 13). Pacesetter says Angeion will join it in vigorously asserting the pacing and defibrillator patents named in the suit.
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.